4-7967055-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001130083.2(ABLIM2):āc.1873G>Cā(p.Glu625Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000421 in 1,613,750 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001130083.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABLIM2 | NM_001130083.2 | c.1873G>C | p.Glu625Gln | missense_variant | 21/21 | ENST00000447017.7 | NP_001123555.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABLIM2 | ENST00000447017.7 | c.1873G>C | p.Glu625Gln | missense_variant | 21/21 | 1 | NM_001130083.2 | ENSP00000393511.2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152142Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 249086Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135180
GnomAD4 exome AF: 0.0000431 AC: 63AN: 1461608Hom.: 0 Cov.: 31 AF XY: 0.0000371 AC XY: 27AN XY: 727100
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152142Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 18, 2024 | The c.1873G>C (p.E625Q) alteration is located in exon 21 (coding exon 21) of the ABLIM2 gene. This alteration results from a G to C substitution at nucleotide position 1873, causing the glutamic acid (E) at amino acid position 625 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at